Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;57(4):383-409.
doi: 10.1007/s10593-021-02916-4. Epub 2021 May 15.

Pyrimido[1,2- a]benzimidazoles: synthesis and perspective of their pharmacological use

Affiliations

Pyrimido[1,2- a]benzimidazoles: synthesis and perspective of their pharmacological use

Victor V Fedotov et al. Chem Heterocycl Compd (N Y). 2021.

Abstract

The review presents data on the synthesis as well as studies of biological activity of new derivatives of pyrimido[1,2-a]benzimidazoles published over the last decade. The bibliography of the review includes 136 sources.

Keywords: 2-aminobenzimidazole; heterocyclization; multicomponent reactions; polynitrogen-containing heteroarenes; pyrimido[1,2-a]benzimidazoles.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Azoloazine-based antiviral drugs.
Figure 2
Figure 2
The drugs based on benzimidazole.
None
Scheme 1
None
Scheme 2
None
Scheme 3
None
Scheme 4
None
Scheme 5
None
Scheme 6
None
Scheme 7
None
Scheme 8
None
Scheme 9
None
Scheme 10
None
Scheme 11
None
Scheme 12
None
Scheme 13
None
Scheme 14
None
Scheme 15
None
Scheme 16
None
Scheme 17
None
Scheme 18
None
Scheme 19
None
Scheme 20
None
Scheme 21
None
Scheme 22
None
Scheme 23
None
Scheme 24
None
Scheme 25
None
Scheme 26
None
Scheme 27
None
Scheme 28
None
Scheme 29
None
Scheme 30
None
Scheme 31
None
Scheme 32
None
Scheme 33
None
Scheme 34
None
Scheme 35
None
Scheme 36
Figure 3
Figure 3
Ionic liquids used in MCR synthesis of pyrimido-[1,2-a]benzimidazoles 140.
Figure 4
Figure 4
The structure of solvent 146.
None
Scheme 37
None
Scheme 38
None
Scheme 39
None
Scheme 40
None
Scheme 41
None
Scheme 42
None
Scheme 43
None
Scheme 44
None
Scheme 45
Figure 5
Figure 5
The structures of catalysts 175 and 176.
None
Scheme 46
None
Scheme 47
None
Scheme 48
None
Scheme 49
None
Scheme 50
None
Scheme 51
None
Scheme 52

Similar articles

Cited by

References

    1. Joule, J.; Mills, K. Khimiya Geterotsiklicheskikh Soedinenii (Chemistry of Heterocyclic Compounds [Russian translation]); Yurovskaya M. А., Ed.; Moscow: Mir, 2004.
    1. Andersen PI, Ianevski A, Lysvand H, Vitkauskiene A, Oksenych V, Bjørås M, Telling K, Lutsar I, Dumpis U, Irie Y, Tenson T, Kantele A, Kainov DE. Int. J. Infect. Dis. 2020;93:268. doi: 10.1016/j.ijid.2020.02.018. - DOI - PMC - PubMed
    1. Álvarez DM, Castillo E, Duarte LF, Arriagada J, Corrales N, Farías MA, Henriquez A, Agurto-Muñoz C, González PA. Front. Microbiol. 2020;11:139. doi: 10.3389/fmicb.2020.00139. - DOI - PMC - PubMed
    1. Al Bujuq, N. Synthesis2020, 3735.
    1. Rusinov, V. L.; Charushin, V. N.; Chupakhin, O. N. Russ. Chem. Bull., Int. Ed.2018, 67, 573. [Izv. Akad. Nauk, Ser. Khim.2018, 573.]

LinkOut - more resources